病理性心室重塑:机制:第2期第1部分
Jana S Burchfield1, Min Xie, Joseph A Hill
1Texas Heart Institute, Houston, TX, USA.
Circulation
|July 24, 2013
概括
高心力衰竭再住院率需要新的治疗方法. 本综述探讨了病态左心室重塑的复杂分子和细胞机制,这对于开发新疗法至关重要.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 尽管取得了进展,但心力衰竭再住院仍然是一个重大的临床挑战.
- 目前的治疗方法还没有完全解决高发病率和死亡率的问题.
- 迫切需要新的治疗策略和医疗器械.
研究的目的:
- 审查心力衰竭中病态左心室重塑背后的分子和细胞机制.
- 突出各种改造过程的相互联系.
- 为了帮助开发更有效的心力衰竭治疗方法.
主要方法:
- 关于分子和细胞机制的文献综述.
- 分析心脏重塑中的相互关联过程.
- 综合当前对病理性心室重塑的理解.
主要成果:
- 左心室重塑涉及复杂的,相互关联的过程,包括肌细胞变化,血管稀疏,纤维化,炎症和电生理学变化.
- 针对单一路径可能是不够的,因为这些事件的相互联系性质.
- 了解这些机制是解决心力衰竭进展的关键.
结论:
- 病理左心室重塑是一个多方面的过程,需要全面的治疗方法.
- 新的治疗方法应该考虑分子和细胞事件的相互作用.
- 对这些机制的进一步研究将推动心力衰竭管理的创新.
相关概念视频
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790


